5 recruiting, 2 active not recruiting, 2 unknown, 1 completed. 5 Not applicable, 3 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Active not recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 3 | Recruiting 3 |
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Node-positive Breast Cancer: new trials by email Literature Review of Node-positive Breast Cancer trials Research Report on Node-positive Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients Axillary Lymph Node Dissection, Axillary Reverse Mapping, Lymphaticovenous Bypass - Node-positive Breast Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 400 | 2026-06-01 | 2026-02-19 |
| Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer Neoadjuvant Pembrolizumab, low dose neoadjuvant boost, High dose neoadjuvant boost - Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 32 | 2026-03-17 | 2026-04-27 |
| Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer CT Scan - Breast Cancer, Node-positive Breast Cancer | Phase 2 | Recruiting | H. Lee Moffitt Cancer Center and Research Institute | 120 | 2025-02-24 | 2026-07-02 |
| Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer Hypofractionated radiation, Ultra-hypofractionated breast/chest wall and regional nodal radiation - Node-positive Breast Cancer | Phase 2 | Recruiting | Washington University School of Medicine | 220 | 2024-08-27 | 2026-01-09 |
| Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy Targeted axillary lymph node dissection - Node-positive Breast Cancer | Phase 4 | Unknown | Assiut University | 30 | 2023-12-01 | 2023-01-09 |
| OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk Ovarian function suppression with endocrine treatments - Breast Cancer, Estrogen Receptor Positive Tumor | Phase 4 | Recruiting | Gangnam Severance Hospital | 418 | 2023-02-06 | 2025-05-22 |
| TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes Targeted axilllary dissection (TAD) followed by axillary lymph node dissection (ALND) - Breast Cancer, Node-positive Breast Cancer | Recruiting | Kliniken Essen-Mitte | 150 | 2022-03-07 | 2023-02-15 | |
| Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI PET/MRI - Breast Cancer Female, Node-positive Breast Cancer | Not applicable | Completed | IRCCS San Raffaele | 109 | 2019-11-04 | 2025-08-01 |
| MUltimodal Targeted Axillary Surgery Systematic axillary ultrasound imaging, Sentinel node, Excision of suspicious lymph nodes - Node-positive Breast Cancer | Not applicable | Unknown | Parc de Salut Mar | 160 | 2019-10-23 | 2021-10-15 |
| Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B - Node-positive Breast Cancer | Not applicable | Active not recruiting | University Hospital, Basel, Switzerland | 1500 | 2018-08-07 | 2026-05-01 |
| Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer External Beam Radiation Therapy - Breast Cancer, Node-positive Breast Cancer | Not applicable | Active not recruiting | Virginia Commonwealth University | 137 | 2015-08-04 | 2026-06-15 |
Breast Neoplasms (7) · Breast Carcinoma In Situ (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (7) · Neoplasms (7) · Neoplasms by Site (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Carcinoma (1) · Carcinoma in Situ (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
DAT protocol 1 (1) · Radiation Dose Hypofractionation (1) · Sentinel Lymph Node Biopsy (1)
Assiut University (1) · Case Comprehensive Cancer Center (1) · Gangnam Severance Hospital (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · IRCCS San Raffaele (1) · Kliniken Essen-Mitte (1) · Parc de Salut Mar (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Hospital, Basel, Switzerland (1) · Virginia Commonwealth University (1) · Washington University School of Medicine (1)
United States (5) · Germany (2) · Italy (2) · South Korea (2) · Argentina (1) · Austria (1) · Canada (1) · Croatia (1) · Greece (1) · Hungary (1) · Latvia (1) · Lithuania (1) · Spain (1) · Switzerland (1)
Dana Casey, MD (1) · Douglas W Arthur, M.D. (1) · Julie E Lang, MD, FACS (1) · Kamran Ahmed (1) · Maria Thomas, M.D., Ph.D. (1) · Maria Vernet-Tomas, MD, PhD (1) · Mattea Reinisch, Dr. (1) · Matthew Mills (1) · Sherko Kuemmel, Prof. Dr. (1) · Sung Gwe Ahn, M.D.,Ph.D. (1) · Walter P. Weber, Prof. (1)
PMID 30514362, PMID 34555676, PMID 37355526, PMID 37903951, PMID 41612658, PMID 42394696, PMID 42492092
2018 (1), R01CA274254 (1)